NCT00437437 2013-06-21
A Phase I Study to Determine the Effect of Food on Brivanib (BMS-582664)
Bristol-Myers Squibb
Phase 1 Completed
Clinical Trials
3 trialsNCT00435669 2009-01-22
A Phase I Study to Determine Absorption, Distribution, Metabolism, and Elimination of a Single Radiolabeled Dose of Brivanib (BMS-582664)
Bristol-Myers Squibb
Phase 1 Completed
NCT00207103 2008-11-04
MAD in Cancer Patients: Safety of BMS-582664 in Patients With Advanced or Metastatic Solid Tumors
Bristol-Myers Squibb
Phase 1 Completed